Suchergebnisse - "Llerena, Adrian"

PubPharm (21)

1

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing : 2020 Update

enthalten in: Clinical pharmacology and therapeutics | 2021

von Karnes, J. | Rettie, A. | Somogyi, A. | +12

2

Pharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting : A PK/PD analysis of the influence of (non-)genetic factors

enthalten in: Experimental and clinical psychopharmacology | 2020

von Magalhães, P. | Alves, G. | Fortuna, A. | +3

3

Real-world clinical characterization of subjects with depression treated with antidepressant drugs focused on (non-)genetic factors, pharmacokinetics, and clinical outcomes : GnG-PK/PD-AD study

enthalten in: Experimental and clinical psychopharmacology | 2020

von Magalhães, P. | Alves, G. | Fortuna, A. | +2

4

Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans

enthalten in: Clinical pharmacology and therapeutics | 2020

von Rodrigues-Soares, F. | Peñas-Lledó, E. | Tarazona-Santos, E. | +44

5

Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans : RIBEF-CEIBA Consortium Report on Population Pharmacogenomics

enthalten in: Omics : a journal of integrative biology | 2018

von Naranjo, M. | Rodrigues-Soares, F. | Peñas-Lledó, E. | +63

6

CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?

enthalten in: Omics : a journal of integrative biology | 2017

von de Andrés, F. | Sosa-Macías, M. | Ramos, B. | +2

7

Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population

enthalten in: Revista de biologia tropical | 2016

von Céspedes-Garro, C. | Rodrigues-Soares, F. | Jiménez-Arce, G. | +6

8

Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes

enthalten in: Expert opinion on drug metabolism & toxicology | 2015

von Céspedes-Garro, C. | Fricke-Galindo, I. | Naranjo, M. | +6

9

Relationship between the CYP2C9 IVS8-109A>T polymorphism and high losartan hydroxylation in healthy Ecuadorian volunteers

enthalten in: Pharmacogenomics | 2014

von Dorado, P. | Gallego, A. | Peñas-LLedó, E. | +2

10

Losartan hydroxylation phenotype in an Ecuadorian population : influence of CYP2C9 genetic polymorphism, habits and gender

enthalten in: Pharmacogenomics | 2012

von Dorado, P. | Beltrán, L. | Machín, E. | +50